MetLife, Inc.
MET · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,426,000 | $1,578,000 | $5,284,000 | $6,554,000 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $1,850,000 | $2,184,000 | $673,000 | $4,813,000 |
| Other Non-Cash | $8,840,000 | $10,498,000 | $5,416,000 | $1,460,000 |
| Operating Cash Flow | $15,116,000 | $14,260,000 | $11,373,000 | $12,827,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1,170,000 | $0 | $4,360,000 |
| Net Acquisitions | -$358,000 | -$755,000 | -$709,000 | $3,270,000 |
| Inv. Purchases | -$82,138,000 | -$84,274,000 | -$104,644,000 | -$109,321,000 |
| Inv. Sales/Matur. | $69,937,000 | $76,096,000 | $108,428,000 | $110,792,000 |
| Other Inv. Act. | $1,066,000 | -$143,000 | -$5,695,000 | -$20,288,000 |
| Investing Cash Flow | -$11,493,000 | -$10,246,000 | -$2,620,000 | -$11,187,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$982,000 | $875,000 | $878,000 | -$632,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$3,207,000 | -$3,103,000 | -$3,326,000 | -$4,803,000 |
| Dividends Paid | -$1,727,000 | -$1,764,000 | -$1,783,000 | -$1,842,000 |
| Other Fin. Act. | $2,785,000 | $1,052,000 | -$5,717,000 | $5,902,000 |
| Financing Cash Flow | -$3,131,000 | -$2,940,000 | -$9,948,000 | -$1,375,000 |
| Forex Effect | -$1,063,000 | -$630,000 | $1,343,000 | -$13,000 |
| Net Chg. in Cash | -$571,000 | $444,000 | $148,000 | $252,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,639,000 | $20,195,000 | $20,047,000 | $19,795,000 |
| End Cash | $20,068,000 | $20,639,000 | $20,195,000 | $20,047,000 |
| Free Cash Flow | $15,116,000 | $14,260,000 | $11,373,000 | $12,827,000 |